 |
#91988. Publications of the AACR
American Association for Cancer Research, AACR, Journals, journal, articles, papers, publications, manuscript, submit, submission system, SmartSubmit, Impact Factor, cited, citations, OnlineFirst, published ahead of print, Author Services Center, High-Impact Science, CCR Focus Archive, Centennial Series Reviews, Meeting Abstracts Online, CR Magazine, Meeting Reports, AACR Education Book, Cancer Medicine 8, Information for Author, Editors, Reviewers, Readers, Subscribers, Librarians, Advertisers, Cancer Research, CanRes, Clinical Cancer Research, CCR, Cancer Epidemiology, Biomarkers & Prevention, CEBP, Molecular Cancer Research, MCR, Molecular Cancer Therapeutics, MCT, Cancer Prevention Research, CaPR, Cancer Discovery, New Issue CCR Focus DNA Repair, Our growing understanding of the mutational complexity of most solid tumors makes it clear that DNA will remain among the most important therapeutic targets for the foreseeable future. That point has been reinforced in recent months by clinical data showing activity of PARP inhibitors in breast cancer in patients who have loss of BRCA1, an important gene in homologous recombination, a double-strand break DNA repair pathway. The CCR Focus section in the September 15th issue of Clinical Cancer Research is aimed at increasing our comprehension of some of the more translational aspects of DNA repair. Read more about other topics by visiting the CCR Focus Archives.
Aacrjournals.org ~
Site Info
Whois
Trace Route
RBL Check
|
